Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SZSE:300049's EV-to-FCF is ranked worse than 81% of 321
companies
in the Biotechnology industry
Industry Median: 18.66
vs SZSE:300049: 53.67
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Inner Mongolia Furui Medical Science Co (SZSE:300049) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Inner Mongolia Furui Medical Science Co's PE Ratio (TTM) for today is calculated as:
Inner Mongolia Furui Medical Science Co's share price for today is ¥43.94.
Inner Mongolia Furui Medical Science Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.590.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Inner Mongolia Furui Medical Science Co EV-to-FCF Related Terms
Inner Mongolia Furui Medical Science Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inner Mongolia Furui Medical Science Co EV-to-FCF Chart
Inner Mongolia Furui Medical Science Co Annual Data
SZSE:300049 vs VRTX, REGN, RVMD: EV-to-FCF Comparison
For the Biotechnology subindustry, Inner Mongolia Furui Medical Science Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inner Mongolia Furui Medical Science Co EV-to-FCF vs Biotechnology Industry
Inner Mongolia Furui Medical Science Co's current Enterprise Value is ¥9,951 Mil.
Inner Mongolia Furui Medical Science Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥228 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inner Mongolia Furui Medical Science Co (SZSE:300049) has a EV-to-FCF of 43.62 as of Aug. 25, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Inner Mongolia Furui Medical Science Co and its competitors. This is near median its historical median of 44.92. According to the industry distribution chart, Inner Mongolia Furui Medical Science Co ranks #260 out of 321 companies in the Biotechnology industry, placing it in the top 81%.
Is Inner Mongolia Furui Medical Science Co's EV-to-FCF too high?
Inner Mongolia Furui Medical Science Co's current EV-to-FCF of 43.62 is near median its 10-year median of 44.92. The Biotechnology industry median EV-to-FCF is 18.66. Inner Mongolia Furui Medical Science Co's value of 43.62 is 133.8% above this industry median. Based on the distribution chart, Inner Mongolia Furui Medical Science Co ranks #260 out of 321 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Inner Mongolia Furui Medical Science Co has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Inner Mongolia Furui Medical Science Co's EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Inner Mongolia Furui Medical Science Co ranks #260 out of 321 companies for EV-to-FCF. This places Inner Mongolia Furui Medical Science Co in the lower half of its industry. The industry median EV-to-FCF is 18.66. Inner Mongolia Furui Medical Science Co's value of 43.62 is 133.8% above this benchmark. While the company's 10-year median is 44.92 vs. the industry median of 18.66, Inner Mongolia Furui Medical Science Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 18.66, based on 321 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Inner Mongolia Furui Medical Science Co's current EV-to-FCF of 43.62 is 133.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Inner Mongolia Furui Medical Science Co and its competitors. For the Biotechnology industry, the median EV-to-FCF is 18.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inner Mongolia Furui Medical Science Co's current EV-to-FCF is 43.62, which is near median its own 10-year median of 44.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inner Mongolia Furui Medical Science Co stock overvalued right now?
Based on GuruFocus' analysis, Inner Mongolia Furui Medical Science Co (SZSE:300049) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥65.97, compared to a current price of ¥43.94 — trading 33.4% below its estimated fair value. The current EV-to-FCF is 43.62, which is near median its 10-year median of 44.92 and 133.8% above the Biotechnology industry median of 18.66. Inner Mongolia Furui Medical Science Co's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Inner Mongolia Furui Medical Science Co (SZSE:300049), the current EV-to-FCF is 43.62 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Inner Mongolia Furui Medical Science Co (SZSE:300049) Overvalued in 2026?
Based on GuruFocus' analysis, Inner Mongolia Furui Medical Science Co stock appears to be undervalued.
The current stock price of ¥43.94 is trading 33.4% below its estimated GF Value™ of ¥65.97.
GuruFocus considers Inner Mongolia Furui Medical Science Co to be Significantly Undervalued.
Key valuation signals for SZSE:300049:
EV-to-FCF: 43.62 (near median its 10-year median of 44.92)
GF Value™: ¥65.97 vs. price of ¥43.94 (33.4% below fair value)
Industry Position: 133.8% above the Biotechnology median (#260 of 321)
No single metric tells the full story. See the SZSE:300049 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Inner Mongolia Furui Medical Science Co Ltd is a China based medical service platform company. It provides disease diagnosis, drug treatment and chronic disease management centered on the liver disease field. The product portfolio of the company includes tablets, capsules, and plaster. In addition, the company is also engaged in providing health-care services.
81GF Score
Get the complete analysis for SZSE:300049
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:300049 has been successfully added to your 
